← Open Payments lookup

GINA KELLEY: Open Payments

NPI 1043078041 · WALLINGFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,972 in 157 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,695 · 2025 $2,972

Food & beverage: $2,972
CompanyPaymentsAmount
ABBVIE INC.51$784
Ardelyx, Inc.23$345
Madrigal Pharmaceuticals6$255
Gilead Sciences, Inc.10$232
Takeda Pharmaceuticals U.S.A., Inc.7$225
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$190
Lilly USA, LLC9$190
Aimmune Therapeutics, Inc.9$183
Phathom Pharmaceuticals, Inc.11$133
QOL Medical, LLC3$99

Products named: IBSRELA, LINZESS, REZDIFFRA, RINVOQ, ZENPEP, ENTYVIO, SKYRIZI, VOQUEZNA.

Industry payments across CT — which companies pay providers there.